CHRW

C.H. Robinson Worldwide, Inc.

60
Fundamentals61/ 100
Valuation54/ 100
Upside potential77/ 100
Risk potential13/ 100

CHRW's fundamentals are mixed: revenue grew 10%, but free cash flow fell 39%. At 24x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth.

CHRW Fundamentals

MetricStatus
Healthy
Healthy
Under pressure
Stable

CHRW's revenue and profitability are currently healthy, and its balance sheet is stable, but its cash flow is under pressure.

CHRW PE Valuation

CHEAPFAIREXPENSIVE11x22x33x44x
CHEAPFAIREXPENSIVE11x22x33x44x
LevelPEPriceVs current
Cheap15x$85.25-37%
Forward18x$134—
Fair24x$132-1.6%
Current24x$134—
Expensive34x$188+40%

Historical ranges are pointers, not guarantees.

CHRW's PE is in its fair range at 24x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.

CHRW Forward outlook

MetricOutlook
Strongly improving
Strong growth
Growth
Stable
Limited
Moderate

Analysts expect earnings and revenue growth for CHRW, with profitability holding steady.

CHRW Risk to reward

ScenarioChangePrice
Upside+43%$191.67
Downside-13%$117.00

Calculated from the latest close: $134.39 on Nov 12.

CHRW's one-year upside scenario is about three times its downside: +43% against −13%.

CHRW Earnings Per Share

Q4 2023: $2.72Q1 2024: $2.54Q2 2024: $2.78Q3 2024: $2.90Q4 2024: $3.86Q1 2025: $4.19Q2 2025: $4.40Q3 2025: $4.94Q4 2025: $4.83Q1 2026: $4.94Q2 2026: $5.24Q3 2026: $5.57Forward: $7.30
Q4 2023: $2.72Q1 2024: $2.54Q2 2024: $2.78Q3 2024: $2.90Q4 2024: $3.86Q1 2025: $4.19Q2 2025: $4.40Q3 2025: $4.94Q4 2025: $4.83Q1 2026: $4.94Q2 2026: $5.24Q3 2026: $5.57Forward: $7.30
QuarterTTM EPSYoY
Forward$7.30+31%
Q3 2026$5.57+13%
Q2 2026$5.24+19%
Q1 2026$4.94+18%
Q4 2025$4.83+25%
Q3 2025$4.94+70%
Q2 2025$4.40+58%
Q1 2025$4.19+65%
Q4 2024$3.86+42%

CHRW's earnings per share have fallen from their peak: $5.57 over the past year, against $8.31 in mid-2022.

CHRW Quarterly Revenue

Q4 2023: $4.2BQ1 2024: $4.4BQ2 2024: $4.5BQ3 2024: $4.6BQ4 2024: $4.2BQ1 2025: $4BQ2 2025: $4.1BQ3 2025: $4.1BQ4 2025: $3.9BQ1 2026: $4BQ2 2026: $4.9BQ3 2026: $5.4B
Q4 2023: $4.2BQ1 2024: $4.4BQ2 2024: $4.5BQ3 2024: $4.6BQ4 2024: $4.2BQ1 2025: $4BQ2 2025: $4.1BQ3 2025: $4.1BQ4 2025: $3.9BQ1 2026: $4BQ2 2026: $4.9BQ3 2026: $5.4B
QuarterRevenueYoY
Q3 2026$5.4B+30%
Q2 2026$4.9B+19%
Q1 2026$4B-0.8%
Q4 2025$3.9B-6.5%
Q3 2025$4.1B-11%
Q2 2025$4.1B-7.7%
Q1 2025$4B-8.3%
Q4 2024$4.2B-0.9%

CHRW's revenue is recovering but still below its 2022 peak: $5.4B last quarter, up 30% from the same quarter a year ago.

CHRW Free Cash Flow

Q4 2023: $43MQ1 2024: −$42MQ2 2024: $160MQ3 2024: $103MQ4 2024: $265MQ1 2025: $103MQ2 2025: $220MQ3 2025: $269MQ4 2025: $302MQ1 2026: $66MQ2 2026: $31MQ3 2026: $120M
Q4 2023: $43MQ1 2024: −$42MQ2 2024: $160MQ3 2024: $103MQ4 2024: $265MQ1 2025: $103MQ2 2025: $220MQ3 2025: $269MQ4 2025: $302MQ1 2026: $66MQ2 2026: $31MQ3 2026: $120M
QuarterFree cash flowYoY
Q3 2026$120.5M-55%
Q2 2026$30.9M-86%
Q1 2026$66M-36%
Q4 2025$302.4M+14%
Q3 2025$269.5M+161%
Q2 2025$219.8M+38%
Q1 2025$103.2M+$145.1M
Q4 2024$265.3M+514%

CHRW still generates free cash flow, though less than at its 2022 peak: $520M over the past year.

CHRW Total Shares

Q4 2023: 120MQ1 2024: 120MQ2 2024: 120MQ3 2024: 121MQ4 2024: 121MQ1 2025: 122MQ2 2025: 121MQ3 2025: 121MQ4 2025: 122MQ1 2026: 121MQ2 2026: 120MQ3 2026: 119M
Q4 2023: 120MQ1 2024: 120MQ2 2024: 120MQ3 2024: 121MQ4 2024: 121MQ1 2025: 122MQ2 2025: 121MQ3 2025: 121MQ4 2025: 122MQ1 2026: 121MQ2 2026: 120MQ3 2026: 119M
PeriodChange %Net change
Quarterly-0.9%-1M shares
1 year-2.2%-2.6M shares
3 years-0.9%-1M shares
5 years-11%-14.7M shares
Available history-13%-17.9M shares

CHRW has 119M diluted shares, down 2.2% from a year ago, with $754M in buybacks over the past year.

CHRW Net Leverage

Q4 2023: 2.3xQ1 2024: 2.7xQ2 2024: 2.4xQ3 2024: 2.1xQ4 2024: 1.6xQ1 2025: 1.5xQ2 2025: 1.4xQ3 2025: 1.2xQ4 2025: 1.0xQ1 2026: 1.3xQ2 2026: 1.6xQ3 2026: 1.7x
Q4 2023: 2.3xQ1 2024: 2.7xQ2 2024: 2.4xQ3 2024: 2.1xQ4 2024: 1.6xQ1 2025: 1.5xQ2 2025: 1.4xQ3 2025: 1.2xQ4 2025: 1.0xQ1 2026: 1.3xQ2 2026: 1.6xQ3 2026: 1.7x
QuarterNet LeverageStatus
Q3 20261.7xHealthy
Q2 20261.6xHealthy
Q1 20261.3xHealthy
Q4 20251.0xHealthy
Q3 20251.2xHealthy
Q2 20251.4xHealthy
Q1 20251.5xHealthy
Q4 20241.6xHealthy

CHRW's net debt is about 1.7 years of its operating earnings (EBITDA), up from 1.2 years a year ago.

CHRW Weekly Momentum

MetricValueStatus
RSI41.0Neutral
Stochastic15.4Oversold

CHRW's weekly RSI is 41 (neutral) and its Stochastic is 15 (oversold).

CHRW PE vs Industrials Sector

MetricCHRWSector medianRelative
PE24x24x0.4% above
PE %51587 pts below

CHRW is trading at 24x earnings, in line with the Industrials sector's median of 24x.

CHRW Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$139.03.3% below
20 week MA$154.113% below
50 week MA$166.919% below
100 week MA$139.03.3% below
200 week MA$115.317% above

CHRW has fallen below most of its moving averages, though it's still 17% above its 200-week average.

CHRW Yearly ROI

YearStart priceEnd priceROI
2020$77.9$94.7+21%
2021$94.7$102.5+8.2%
2022$102.5$93.1-9.1%
2023$93.1$86.4-7.2%
2024$86.4$103.9+20%
2025$103.9$164.6+58%
2026 YTD$164.6$134.4-18%

CHRW has finished higher in four of the last six years. It's down 18% so far in 2026.

Give your agent the market.

Get API key